CIE-10

CIE-10-código C94

You are here: Inicio > CIE-10 > C00-D49 > C00-C97 > C81-C96

- CIE-10
Clasificación Internacional de Enfermedades
- C00-D49
Tumores [neoplasias]
- C00-C97
Tumores [neoplasias] malignos
- C81-C96
Tumores [neoplasias] malignos del tejido linfático, de los órganos hematopoyéticos y de tejidos afines

C94

Otras leucemias de tipo celular especificado

CIE-10 Сódigo C94 para Otras leucemias de tipo celular especificado

Incluye: los tipos morfológicos clasificables en M984, M9850, M9900, M9910, M9931–M9932 con código de comportamiento /3

Excluye: leucemia de células plasmáticas (C90.1)

reticuloendoteliosis leucémica (C91.4)

C94.0
Eritremia aguda y eritroleucemia
C94.1
Eritremia crónica
C94.2
Leucemia megacarioblástica aguda
C94.3
Leucemia de mastocitos
C94.4
Panmielosis aguda
C94.5
Mielofibrosis aguda
C94.7
Otras leucemias especificadas
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us